Processing your payment...
Please do not close your browser.

Cervical Cancer Diagnostics Market - Global Growth, Trends and Forecast (2022 - 2027) By Types, By Application, By Regions and By Key Players: Abbott Laboratories (NYSE: ABT), Dickinson and Company (NYSE: BDX), The Cooper Companies, Inc. (NYSE: COO)

27 May, 2022 | 190 Pages
Shares
facebook sharing button
linkedin sharing button
twitter sharing button
sharethis sharing button

Over the next five years the Cervical Cancer Diagnostics market will register a 5.9% CAGR in terms of revenue, the global market size will reach USD 1.52 billion by 2027.



Cervical Cancer Diagnostics Market Overview



In 2017, the global cervical cancer diagnostic market was worth USD 7 billion, and it is expected to increase at a CAGR of 5.9% over the next five years. Women between the ages of 20 and 60 are more likely to get cervical cancer, which is projected to boost cervical cancer screening and diagnostic processes.



Cervical cancer is one of the leading causes of death among American women. Cervical cancer is quite common in the United States, which is a major driver of market growth. According to the American Cancer Society, 12,990 new instances of invasive cervical cancer will be detected in 2016, with 4,120 women dying as a result. The fatality rate from cervical cancer has decreased by up to 50% in the previous 40 years, showing that screening procedures such as the Pap test and HPV testing are becoming more widely used. In the United States, Hispanic women are more likely than African-Americans, Pacific Islanders, and white women to acquire cervical cancer. Alaskans and American Indians are expected to be at the lowest risk of developing it.



The report aspects discussed the profile of the top manufacturers of the global Cervical Cancer Diagnostics market. These aspects include financial status of major companies, trending advancements and entire market scenario. Growth of the report have examined Cervical Cancer Diagnostics Market production, demand and growth potential, geographic analysis, as well as current market developments in various regions and countries.



Who are the Major Players in Cervical Cancer Diagnostics Market?



The Cervical Cancer Diagnostics Market is growing at a very fast pace and has seen the focus of many local and regional vendors offering precise application products for multiple end users. The three dependencies for the status of major companies in the market are: company profile, profitable gross margin, the prices they charge. These are the main players in this market DYSIS Medical Ltd., Abbott Laboratories (NYSE: ABT), Becton, Dickinson and Company (NYSE: BDX), The Cooper Companies, Inc. (NYSE: COO), Danaher Corporation (NYSE: DHR), F. Hoffmann-La Roche AG, Quest Diagnostics, Arbor Vita Corporation, Hologic, Inc., Zilico Ltd, and Qiagen and others.






Industry News:



BD Receives FDA Approval for New Automated Cervical Cancer Screening System



BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has received U.S. Food and Drug Administration (FDA) approval for its BD Totalys™ MultiProcessor and BD Totalys™ SlidePrep instruments.



Together with the BD FocalPoint™ SlideProfiler, these innovations comprise the full BD Totalys System, which further automates slide preparation, imaging and review for use in cervical cancer screening, as well as providing ancillary testing aliquot capability



Cervical Cancer Diagnostics Market provides details by vendors, including company total revenue (financials), company overview, market potential, global presence, his business report briefly talks about market performance of each business sector covering growth factors and sales volume. this analysis provides the This Cervical Cancer Diagnostics Market analysis report provides recent trends, granular level data covering market size and share. It provides all the recent updates about CORONA virus and its impact on world economy and human health. By getting this data, key players can obtain profit making and right business opportunities for future growth. Its further guides to increase the product demand and business expansion.



What are the major Applications, Types and Regions for Cervical Cancer Diagnostics Market?



By Type, it is segmented into




  • Pap Smear Test

  • Colposcopy Test

  • ECC Test

  • HPV Test



By Applications it is segmented into




  • Hospitals and Clinics

  • Laboratories

  • Diagnosing Centers

  • Others



Cervical Cancer Diagnostics Market Regional Analysis



The cervical cancer diagnostics market in North America is expected to develop at a healthy rate through 2028. This is attributable to the creation of several cancer treatment programmes aimed at assisting low-income individuals. The NBCCEDP programme, for example, allows the CDC to assist low-income people who are underinsured or uninsured in obtaining timely cervical and breast cancer screening, treatment, and diagnostic services. The programme also offers patient navigation services to assist patients in obtaining timely access to high-quality care and overcoming obstacles.




  • North America

    • US

    • Canada



  • Europe

    • Germany

    • France

    • UK

    • Italy

    • Spain

    • Rest of Europe



  • Asia-Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific



  • Rest of the World

    • Middle East & Africa

    • Latin America





The Cervical Cancer Diagnostics Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global Cervical Cancer Diagnostics Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.



What is our Cervical Cancer Diagnostics Market report scope?























































 



Report Attributes



 



 



Report Details



 



Forecast Period 2022 to 2027 CAGR



 



CAGR of 5.9% during the review period (2022 to 2027).



 



By Type




  • Pap Smear Test

  • Colposcopy Test

  • ECC Test

  • HPV Test



 



By Application




  • Hospitals and Clinics

  • Laboratories

  • Diagnosing Centers

  • Others



 



 



 



By Companies



 



 



DYSIS Medical Ltd., Abbott Laboratories, Becton, Dickinson and Company, The Cooper Companies, Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Quest Diagnostics, Arbor Vita Corporation, Hologic, Inc., Zilico Ltd, and Qiagen



 



 



 



Regions Covered



 




  • North America

  • Europe

  • Asia-Pacific

  • Rest of the World



 



 



 



 



 



 



 



 



Countries Covered




  • US

  • Canada

  • Germany

  • France

  • UK

  • Italy

  • Spain

  • Rest of Europe

  • China

  • Japan

  • India

  • Australia

  • South Korea

  • Rest of Asia-Pacific

  • Middle East & Africa

  • Latin America



 



Base Year



 



 



2022



 



Historical Year



 



 



2017 to 2021



Forecast Year



 



2022 to 2027



Number of Pages



190



 



Customization Available



 



 



Yes, the report can be customized as per your needs




 Key Takeaways from this Cervical Cancer Diagnostics Report




  • Evaluate Cervical Cancer Diagnostics market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level - for product types, end use applications and by different industry verticals.

  • Understand the different dynamics influencing the market - growth driving factors, specific challenges and hidden opportunities.

  • Get in-depth insights on your competitor performance – revenue, shares, business strategies, financial benchmarking, product benchmarking, SWOT analysis and more.

  • Analyze the sales and distribution channels across geographies to enhance top-line revenues.

  • Understand the demanding supply chain with a deep dive on the value augmentation at each, in order to optimize value and bring efficiencies in your processes.

  • Get a quick outlook on the Cervical Cancer Diagnostics market entropy - M&A's, deals, partnerships, product launches of all key players for the past 4 years.

  • Evaluate the import-export statistics, supply-demand and competitive landscape for more than top 20 countries globally for the market.



All our reports are custom made to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report as your needs.



Frequently Asked Questions



What is the study period of this market?



The Cervical Cancer Diagnostics Market is studied from 2017 - 2027.



What is the growth rate of Cervical Cancer Diagnostics Market?



The Cervical Cancer Diagnostics Market is growing at a CAGR of 5.9% over the next 5 years.



Who are the key players in Cervical Cancer Diagnostics Market?



DYSIS Medical Ltd., Abbott Laboratories, Becton, Dickinson and Company, The Cooper Companies, Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Quest Diagnostics, Arbor Vita Corporation, Hologic, Inc., Zilico Ltd, and Qiagen



What region does this Cervical Cancer Diagnostics Market report covers?



North America (the United States, Canada, and Mexico)



Europe (Germany, France, UK, Russia, and Italy)



Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)



South America (Brazil, Argentina, Colombia, etc.)



The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)



What are the significant types of Cervical Cancer Diagnostics Market?



Pap Smear Test, Colposcopy Test, ECC Test, HPV Test



What are the major end-use applications of Cervical Cancer Diagnostics Market?



Hospitals and Clinics, Laboratories, Diagnosing Centers, Others


  1. INTRODUCTION

    1. MARKET DEFINATION

    2. MARKET DYNAMICS

    3. MARKET SEGMENTATION

    4. REPORT TIMLINES

    5. KEY STAKEHOLDERS



  2. RESEARCH METHODOLOGY

    1. DATA MINING

      1. SECONDARY RESEARCH

      2. PRIMARY RESEARCH

      3. SUBJECT MATTER EXPERT ADVICE



    2. QUALITY CHECK

    3. FINAL REVIEW

      1. DATA TRIANGULATION

      2. BOTTOM-UP APPROACH

      3. TOP-DOWN APPROACH



    4. RESEARCH FLOW



  3. EXECUTIVE SUMMARY

    1. INTRODUCTION

    2. GLOBAL CERVICAL CANCER DIAGNOSTICS MARKET BY TYPES

    3. GLOBAL CERVICAL CANCER DIAGNOSTICS MARKET BY APPLICATION



  4. MARKET DYNAMICS

    1. DRIVERS

      1. INCREASING DEMAND OF CERVICAL CANCER DIAGNOSTICS



    2. RESTRAINTS

      1. STRINGENT ENVIRONMENTAL REGUALTIONS

      2. HIGH COST OF RAW MATERIAL



    3. OPPORTUNITIES

      1. CERVICAL CANCER DIAGNOSTICS GROWTH

      2. APPLICATION OF CERVICAL CANCER DIAGNOSTICS



    4. IMPACT OF COVID 19



  5. GLOBAL CERVICAL CANCER DIAGNOSTICS MARKET, BY TYPES

    1. INTRODUCTION

    2. PAP SMEAR TEST

    3. COLPOSCOPY TEST

    4. ECC TEST

    5. HPV TEST

    6. OTHERS



  6. GLOBAL CERVICAL CANCER DIAGNOSTICS MARKET, BY APPLICATIONS

    1. INTRODUCTION

    2. HOSPITALS AND CLINICS

    3. LABORATORIES

    4. DIAGNOSING CENTERS

    5. OTHERS



  7. GLOBAL CERVICAL CANCER DIAGNOSTICS MARKET, BY REGION

    1. NORTH AMERICA

      1. US

      2. CANADA

      3. MEXICO



    2. EUROPE

      1. GERMANY

      2. FRANCE

      3. UK

      4. ITALY

      5. RUSSIA

      6. REST OF EUROPE



    3. APAC

      1. CHINA

      2. SOUTH KOREA

      3. JAPAN

      4. INDIA

      5. AUSTRALIA

      6. ASEAN

      7. REST OF APAC



    4. MIDDLE EAST & AFRICA

      1. SAUDI ARABIA

      2. UAE

      3. SOUTH AFRICA

      4. TURKEY

      5. REST OF MEA



    5. SOUTH AMERICA

      1. BRAZIL

      2. REST OF MEA

      3. ARGENTINA

      4. REST OF SOUTH AMERICA





  8. COMPETITIVE LANDSCAPE

    1. MERGERS, ACQUISITIONS, JOINT VENTURES, COLLABORATIONS,

    2. AND AGREEMENTS

      1. KEY DEVELOPMENT



    3. MARKET SHARE (%) **/RANKING ANALYSIS

    4. STRATEGIES ADOPTED BY LEADING PLAYERS



  9. COMPANY PROFILES

    1. BUSINESS OVERVIEW

    2. COMPANY SNAPSHOT

    3. PRODUCT BENCHMARKING

    4. STRATEGIC INITIATIVES

      1.  DYSIS Medical Ltd.

      2.  Abbott Laboratories (NYSE: ABT)

      3.  Becton

      4.  Dickinson and Company (NYSE: BDX)

      5.  The Cooper Companies

      6.  Inc. (NYSE: COO)

      7.  Danaher Corporation (NYSE: DHR)

      8.  F. Hoffmann-La Roche AG

      9.  Quest Diagnostics

      10.  Arbor Vita Corporation

      11.  Hologic Inc.

      12.  Zilico Ltd and Qiagen





SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

  • Single User License
    $2500
  • Site License
    $3000
  • Global License
    $5000

How can we help you?

Reach us with your research requirements and we shall provide the optimum solution to suit your needs.

Curioust about Multiple Reports?

Discounts available for multiple report purchases.

Contact Us

Our Clients

  • 3M
  • Merck
  • IBM
  • Dow
  • Henkel
  • AirBus
  • Cummins
  • Intel
  • Sony